top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
Descrizione fisica 1 online resource (iii, 99 p.) : ill
Soggetto topico Drugs - Safety regulations - United States
Drugs - United States - Testing
Soggetto non controllato United States
Drugs
Political science
Medical
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Ensuring drug safety
Record Nr. UNINA-9910693918303321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001
Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001
Descrizione fisica 1 online resource (iii, 166 p.)
Soggetto topico Pharmaceutical policy - United States
Drugs - United States - Testing
Pediatric pharmacology - United States
Soggetto non controllato United States
Pharmaceutical policy
Drugs
Pediatric pharmacology
Political science
Medical
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Evaluating the effectiveness of the Food And Drug Administration Modernization Act
Record Nr. UNINA-9910689420003321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Examining patient access to investigational drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. October 3, 2017
Examining patient access to investigational drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. October 3, 2017
Pubbl/distr/stampa Washington : , : U.S. Government Publishing Office, , 2018
Descrizione fisica 1 online resource (iv, 235 pages) : photographs
Soggetto topico Clinical trials - United States
Clinical trials - Moral and ethical aspects - United States
Drugs - United States - Testing
Drugs - Testing - Moral and ethical aspects - United States
Soggetto genere / forma Legislative hearings.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Examining patient access to investigational drugs
Record Nr. UNINA-9910711779603321
Washington : , : U.S. Government Publishing Office, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005
Descrizione fisica 1 online resource (iii, 93 p.) : ill
Soggetto topico Drugs - United States - Testing
Pharmaceutical policy - United States
Soggetto non controllato United States
Drugs
Pharmaceutical policy
Political science
Medical
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti FDA's drug approval process
Record Nr. UNINA-9910693940603321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
FDA's monitoring of postmarketing study commitments
FDA's monitoring of postmarketing study commitments
Pubbl/distr/stampa [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2006
Descrizione fisica 1 online resource (iv, 38 pages) : illustrations
Soggetto topico Drugs - United States - Testing
Clinical trials - Government policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Food and Drug Administration's monitoring of postmarketing study commitments
FDA's monitoring of postmarketing study commitments
Record Nr. UNINA-9910707486603321
[Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2006
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
FDA's role in the evaluation of Avandia's safety [[electronic resource] ] : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007
FDA's role in the evaluation of Avandia's safety [[electronic resource] ] : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007
Pubbl/distr/stampa Washington : , : U.S. G.P.O., , 2009
Descrizione fisica iii, 138 pages : digital, PDF file
Soggetto topico Rosiglitazone - Side effects
Diabetes - Chemotherapy
Drugs - United States - Testing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti FDA's role in the evaluation of Avandia's safety
Record Nr. UNINA-9910693458503321
Washington : , : U.S. G.P.O., , 2009
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The Food and Drug Administration's critical mission and challenges for the future : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, May 1, 2007
The Food and Drug Administration's critical mission and challenges for the future : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, May 1, 2007
Descrizione fisica 1 online resource (iii, 79 p.)
Soggetto topico Drugs - United States - Testing
Food adulteration and inspection - United States
Soggetto non controllato United States
Drugs
Food adulteration and inspection
Political science
Medical
Technology & engineering
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Food and Drug Administration's critical mission and challenges for the future
Record Nr. UNINA-9910694472003321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The Food and Drug Administration's generic drug review process
The Food and Drug Administration's generic drug review process
Pubbl/distr/stampa [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2008
Descrizione fisica 1 online resource (iii, 36 pages) : illustrations
Soggetto topico Generic drugs - Government policy - United States
Drugs - United States - Testing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Food and Drug Administration's generic drug review process
Record Nr. UNINA-9910707485903321
[Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Food and Drug Administration: information on Mifeprex labeling changes and ongoing monitoring efforts : report to congressional requesters
Food and Drug Administration: information on Mifeprex labeling changes and ongoing monitoring efforts : report to congressional requesters
Pubbl/distr/stampa [Washington, D.C.] : , : United States Government Accountability Office, , 2018
Descrizione fisica 1 online resource (ii, 29 pages)
Soggetto topico Mifepristone - United States - Testing
Drugs - Labeling - Standards - United States
Drugs - United States - Testing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Food and Drug Administration
Record Nr. UNINA-9910706904703321
[Washington, D.C.] : , : United States Government Accountability Office, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
From test tube to patient [[electronic resource] ] : improving health through human drugs / / Marcia L. Trenter, editor
From test tube to patient [[electronic resource] ] : improving health through human drugs / / Marcia L. Trenter, editor
Pubbl/distr/stampa [Rockville, MD] : , : U.S. Food and Drug Administration, Center for Drug Evaluation and Research, , [1999]
Soggetto topico Drugs - Research - United States
Drugs - United States - Testing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti From test tube to patient
Record Nr. UNINA-9910691221703321
[Rockville, MD] : , : U.S. Food and Drug Administration, Center for Drug Evaluation and Research, , [1999]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui